Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on American Food & Beverage Online.
Americold Ireland Achieves Exclusive U.S. Meat Export Certification and Five AA-Rated Audits, Reinforcing Global Cold Chain Leadership
ATLANTA, GA., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Americold, a global leader in temperature-controlled logistics, real estate, and value-added services, today announced that its Dublin facility has been certified by Ireland’s Department of...
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband received final meeting minutes from FDA and is...
PMI Foods Commends Section 301 Investigation into Phase One Agreement, Highlights Importance of U.S.-China Trade Relationship
Salt Lake City, Utah, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Following the United States Trade Representative’s (USTR) announcement of a Section 301 investigation into China’s implementation of the Phase One Trade Agreement, PMI Foods President Darin...
Governor Kotek Demands Immediate USDA Action to Protect Food Assistance for 757,000 Oregonians During Federal Shutdown
Seoul, S. Korea — Today, Governor Tina Kotek and Oregon elected officials sent a letter to U.S. Secretary of Agriculture Brooke L. Rollins urging the U.S. Department of Agriculture (USDA) to take immediate action to ensure that Supplemental...
Owner: American Government
Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma
FLORHAM PARK, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the...
Revolution Medicines’ RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer
REDWOOD CITY, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that the U.S. Food and...
CAROLYN RUBIN SELECTED FOR IAOTP’S BOMBSHELL BOSS BABE AWARD
Carolyn Rubin will be honored and inducted into Bombshell Boss Babes at the International Association of Top Professionals annual awards gala NEW YORK, NY, UNITED STATES, October 27, 2025 /EINPresswire.com/ -- The International Association of...
Muddy Water Adventures Showcases Wrangell’s Local Advantage for Alaska Bear Viewing Tours
Muddy Water Adventures highlights Wrangell’s local insight and experience for safe, authentic bear viewing at Alaska’s Anan Bear and Wildlife Observatory. WRANGELL, AK, UNITED STATES, October 27, 2025 /EINPresswire.com/ -- Muddy Water...
Video, Audio, Photos & Rush Transcript: Governor Hochul Holds Rally with New Yorkers Impacted by Republican Cuts and Announces $30 Million in Emergency Food Assistance Funds
Earlier today, Governor Hochul rallied with New Yorkers impacted by Washington Republicans' devastating cuts to health care, food assistance and other critical programs. With nearly three million New Yorkers at risk of losing the food assistance...
Owner: American Government
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR’s BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHS Full enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a...
Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit
DUBLIN and BRIDGEWATER, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care worldwide, today issued the following statement in response to the recent...
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
Trial initiation in food allergy follows promising results in Phase 2 trial in chronic spontaneous urticaria, another IgE-driven condition RAPT seeks to develop a differentiated anti-IgE therapy for the many patients with food allergies SOUTH SAN...
NEW STUDY SHOWS 43% DROP IN PEANUT ALLERGIES BY FEEDING EARLY & OFTEN - EXACTLY WHY GROWHAPPY WAS CREATED
Research validates GrowHappy’s ImmunoNutrition approach, translating decades of food allergy research science into real, practical products for families DALLAS, TX, UNITED STATES, October 28, 2025 /EINPresswire.com/ -- Last week, a...
Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025
ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA Scientific Sessions 2025 in New Orleans, LA, November...
Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025
Data from the Phase 1 CARLYSLE study in severe refractory systemic lupus erythematosus (srSLE) suggests obe-cel is well tolerated with no ICANS or high-grade CRS; 50 million cell dose selected for Phase 2 pivotal study Preliminary efficacy data...
A Decade After FDA’s Gluten-Free Rule, Experts Call for Optimal Protection
Advocating stricter safety to support parents’ daily food choices for their gluten-sensitive children MA, UNITED STATES, October 27, 2025 /EINPresswire.com/ -- Since the U.S. Food and Drug Administration (FDA) established its 20...
Flavored Syrup Market to Hit USD 77.93 Bn by 2032, Fueled by Sugar-Free Innovations, Organic Trends & Café Culture Boom
Flavored Syrup Market size was valued at USD 56.08 Bn. in 2024, is expected to grow at a CAGR of 4.2 % from 2025 to 2032, reaching nearly USD 77.93 Bn. by 2032. WILMINGTON, DE, UNITED STATES, October 28, 2025 /EINPresswire.com/ -- Discover how...
System in Package Market Size, Share, Trends, and Forecast (2025–2032) to Reach USD 23.86 Billion
System in Package Market size was valued at USD 11.29 Billion in 2024 and is projected to reach USD 23.86 Billion by 2032, growing at a robust CAGR of 9.8%. WILMINGTON, DE, UNITED STATES, October 28, 2025 /EINPresswire.com/ -- Global System in...
Foliar Fertilizer Market to Reach USD 12.45 Bn by 2032, Driven by 5.4% CAGR, Sustainable Farming
Foliar Fertilizer Market is expected to grow at a CAGR of 5.4% during the forecast period. is expected to reach US$ 12.45 Bn. in 2032 from US$ 8.17 Bn in 2024. ATLANTA, GA, UNITED STATES, October 28, 2025 /EINPresswire.com/ -- Discover the...
Robot as a Service (RaaS) Industry Outlook 2025–2032 | Global Value to Hit USD 8.2 Billion at 18% CAGR
Robot as a Service Market Trends 2025–2032 | Global Growth Driven by AI & Automation AUSTIN, TX, UNITED STATES, October 28, 2025 /EINPresswire.com/ -- Robot as a Service Industry Overview The Robot as a Service (RaaS) market is transforming the...